Two class 1.1 innovative drugs in Jiangsu Province have been approved for listing this year
-
Last Update: 2014-12-02
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
The two innovative drugs of 1.1 class were apatinib mesylate, a new anti gastric cancer drug of Hengrui medicine, and moroxynidazole, an anti infection drug of hausen medicine These two new drugs have been successively supported by the provincial science and technology plan and the national major new drug creation project Apatinib mesylate is the world's first small molecule anti angiogenic targeted drug for the treatment of advanced gastric cancer, and the only oral drug targeted for gastric cancer Morpholinidazole is a new generation of nitroimidazoles, which is mainly used in the surgical and gynecological infections caused by anaerobic bacteria.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
